272 related articles for article (PubMed ID: 19649206)
1. Distinct HIC1-SIRT1-p53 loop deregulation in lung squamous carcinoma and adenocarcinoma patients.
Tseng RC; Lee CC; Hsu HS; Tzao C; Wang YC
Neoplasia; 2009 Aug; 11(8):763-70. PubMed ID: 19649206
[TBL] [Abstract][Full Text] [Related]
2. Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses.
Chen WY; Wang DH; Yen RC; Luo J; Gu W; Baylin SB
Cell; 2005 Nov; 123(3):437-48. PubMed ID: 16269335
[TBL] [Abstract][Full Text] [Related]
3. Hypermethylation of HIC1 promoter and aberrant expression of HIC1/SIRT1 might contribute to the carcinogenesis of pancreatic cancer.
Zhao G; Qin Q; Zhang J; Liu Y; Deng S; Liu L; Wang B; Tian K; Wang C
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S301-11. PubMed ID: 22552606
[TBL] [Abstract][Full Text] [Related]
4. Hypermethylation of the HIC1 promoter and aberrant expression of HIC1/SIRT1 contribute to the development of thyroid papillary carcinoma.
Wu W; Zhang L; Lin J; Huang H; Shi B; Lin X; Huang Z; Wang C; Qiu J; Wei X
Oncotarget; 2016 Dec; 7(51):84416-84427. PubMed ID: 27793057
[TBL] [Abstract][Full Text] [Related]
5. Scavenger chemokine (CXC motif) receptor 7 (CXCR7) is a direct target gene of HIC1 (hypermethylated in cancer 1).
Van Rechem C; Rood BR; Touka M; Pinte S; Jenal M; Guérardel C; Ramsey K; Monté D; Bégue A; Tschan MP; Stephan DA; Leprince D
J Biol Chem; 2009 Jul; 284(31):20927-35. PubMed ID: 19525223
[TBL] [Abstract][Full Text] [Related]
6. The tumor suppressor gene hypermethylated in cancer 1 is transcriptionally regulated by E2F1.
Jenal M; Trinh E; Britschgi C; Britschgi A; Roh V; Vorburger SA; Tobler A; Leprince D; Fey MF; Helin K; Tschan MP
Mol Cancer Res; 2009 Jun; 7(6):916-22. PubMed ID: 19491197
[TBL] [Abstract][Full Text] [Related]
7. An acetylation/deacetylation-SUMOylation switch through a phylogenetically conserved psiKXEP motif in the tumor suppressor HIC1 regulates transcriptional repression activity.
Stankovic-Valentin N; Deltour S; Seeler J; Pinte S; Vergoten G; Guérardel C; Dejean A; Leprince D
Mol Cell Biol; 2007 Apr; 27(7):2661-75. PubMed ID: 17283066
[TBL] [Abstract][Full Text] [Related]
8. Cytoplasmic Ape1 expression elevated by p53 aberration may predict survival and relapse in resected non-small cell lung cancer.
Wu HH; Chu YC; Wang L; Tsai LH; Lee MC; Chen CY; Shieh SH; Cheng YW; Lee H
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S336-47. PubMed ID: 22688662
[TBL] [Abstract][Full Text] [Related]
9. Metformin and tenovin-6 synergistically induces apoptosis through LKB1-independent SIRT1 down-regulation in non-small cell lung cancer cells.
Lee BB; Kim Y; Kim D; Cho EY; Han J; Kim HK; Shim YM; Kim DH
J Cell Mol Med; 2019 Apr; 23(4):2872-2889. PubMed ID: 30710424
[TBL] [Abstract][Full Text] [Related]
10. HIC1 (Hypermethylated in Cancer 1) epigenetic silencing in tumors.
Fleuriel C; Touka M; Boulay G; Guérardel C; Rood BR; Leprince D
Int J Biochem Cell Biol; 2009 Jan; 41(1):26-33. PubMed ID: 18723112
[TBL] [Abstract][Full Text] [Related]
11. Hypermethylated in cancer 1(HIC1) suppresses non-small cell lung cancer progression by targeting interleukin-6/Stat3 pathway.
Wang X; Wang Y; Xiao G; Wang J; Zu L; Hao M; Sun X; Fu Y; Hu G; Wang J
Oncotarget; 2016 May; 7(21):30350-64. PubMed ID: 27107418
[TBL] [Abstract][Full Text] [Related]
12. Loss of special AT-rich binding protein 1 expression is a marker of poor survival in lung cancer.
Selinger CI; Cooper WA; Al-Sohaily S; Mladenova DN; Pangon L; Kennedy CW; McCaughan BC; Stirzaker C; Kohonen-Corish MR
J Thorac Oncol; 2011 Jul; 6(7):1179-89. PubMed ID: 21597389
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic silencing of HIC1 promotes epithelial-mesenchymal transition and drives progression in esophageal squamous cell carcinoma.
Li P; Liu X; Dong ZM; Ling ZQ
Oncotarget; 2015 Nov; 6(35):38151-65. PubMed ID: 26510908
[TBL] [Abstract][Full Text] [Related]
14. Molecular dissection of the interaction between HIC1 and SIRT1.
Dehennaut V; Loison I; Pinte S; Leprince D
Biochem Biophys Res Commun; 2012 May; 421(2):384-8. PubMed ID: 22510409
[TBL] [Abstract][Full Text] [Related]
15. 5' cytosine-phospho-guanine island methylation is responsible for p14ARF inactivation and inversely correlates with p53 overexpression in resected non-small cell lung cancer.
Hsu HS; Wang YC; Tseng RC; Chang JW; Chen JT; Shih CM; Chen CY; Wang YC
Clin Cancer Res; 2004 Jul; 10(14):4734-41. PubMed ID: 15269146
[TBL] [Abstract][Full Text] [Related]
16. Association of O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation with p53 mutation occurrence in non-small cell lung cancer with different histology, gender, and smoking status.
Wu JY; Wang J; Lai JC; Cheng YW; Yeh KT; Wu TC; Chen CY; Lee H
Ann Surg Oncol; 2008 Nov; 15(11):3272-7. PubMed ID: 18712569
[TBL] [Abstract][Full Text] [Related]
17. Reduced transcription of the RB2/p130 gene in human lung cancer.
Xue Jun H; Gemma A; Hosoya Y; Matsuda K; Nara M; Hosomi Y; Okano T; Kurimoto F; Seike M; Takenaka K; Yoshimura A; Toyota M; Kudoh S
Mol Carcinog; 2003 Nov; 38(3):124-9. PubMed ID: 14587097
[TBL] [Abstract][Full Text] [Related]
18. Associations of MDM2 SNP309, transcriptional activity, mRNA expression, and survival in stage I non-small-cell lung cancer patients with wild-type p53 tumors.
Chien WP; Wong RH; Cheng YW; Chen CY; Lee H
Ann Surg Oncol; 2010 Apr; 17(4):1194-202. PubMed ID: 19941079
[TBL] [Abstract][Full Text] [Related]
19. Negative regulation of the deacetylase SIRT1 by DBC1.
Zhao W; Kruse JP; Tang Y; Jung SY; Qin J; Gu W
Nature; 2008 Jan; 451(7178):587-90. PubMed ID: 18235502
[TBL] [Abstract][Full Text] [Related]
20. Mutually exclusive inactivation of DMP1 and ARF/p53 in lung cancer.
Mallakin A; Sugiyama T; Taneja P; Matise LA; Frazier DP; Choudhary M; Hawkins GA; D'Agostino RB; Willingham MC; Inoue K
Cancer Cell; 2007 Oct; 12(4):381-94. PubMed ID: 17936562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
